Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Date

Monday, 5 February 2024, All day
Thursday, 8 February 2024, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page